Summary

The global infection surveillance solutions market is to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%. The growth in this market can primarily be attributed to the increasing incidence of HAIs and increasing surgical procedures. The rising healthcare expenditure, an increasing number of surgeries, the growing geriatric population, and the increasing incidence of chronic diseases are the other factors driving the growth of this market. Currently, with the surge in COVID-19 cases, there is an increased focus on personal hygiene, coupled with the need to track and monitor the spread of COVID-19 infection
However, the high installation costs of infection surveillance solution platforms and the reluctance of healthcare professionals to adopt advanced healthcare IT solutions are expected to limit the growth of this market to a certain extent.



Based on the products and services, the software segment accounted for the largest share during the forecast period
Based on product the infection surveillance solutions market is segmented into infection surveillance software solutions and infection surveillance services. The infection surveillance software segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the increasing need for preventing HAIs and the growing number of surgical procedures leading to surgical site infections.


Based on the software segment, on-premise software accounted for the largest share during the forecast period
Based on type, the infection surveillance software market is segmented into on-premise and web-based software. The on-premise software segment accounted for the largest share of the infection surveillance software market in 2020. The large share of this segment is mainly attributed to the need for maintaining access to healthcare IT solutions and reduce the risk of data breaches & external attacks.


Based on services, product support and maintenance segment accounted for the largest share during the forecast period
Based on type, the infection surveillance services market is segmented into product support and maintenance services, training and consulting services, and implementation services. The product support and maintenance services segment accounted for the largest share of the infection surveillance services market. Product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company’s technical knowledge base, gain support from its product support team, and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment



Based on end user segment, hospitals accounted for the largest share during the forecast period
Based on end user, the infection surveillance solutions market is segmented into hospitals, long-term care facilities, and other end users. In 2020, the hospitals segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals.

North America accounted for the largest share in the infection surveillance solutions market during the forecast period
In 2020, North America accounted for the largest share of the infection surveillance solutions market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this region can be attributed to factors such as the growing consolidation among healthcare providers, widespread adoption of healthcare IT solutions to curtail the rising healthcare costs, increasing incidence of HAIs, and the rising number of COVID-19 patients in the US.



Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Infection Surveillance Solutions Market

The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).
Research Coverage:
The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as products & services, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products& services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by products & services and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market
• Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION & SCOPE 23
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 24
1.2.2 MARKET SEGMENTATION 24
FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION 24
1.2.3 YEARS CONSIDERED FOR THE STUDY 25
1.3 CURRENCY 25
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 25
1.4 STAKEHOLDERS 26
1.5 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH APPROACH 28
2.2 RESEARCH METHODOLOGY DESIGN 28
FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN 28
2.2.1 SECONDARY RESEARCH 29
2.2.1.1 Key data from secondary sources 30
2.2.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 31
2.2.2.1 Key data from primary sources 32
2.2.2.2 Insights from primary experts 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET 34
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 35
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37
FIGURE 9 CAGR PROJECTIONS 37
FIGURE 10 TOP-DOWN APPROACH 38
2.4 DATA TRIANGULATION APPROACH 39
FIGURE 11 DATA TRIANGULATION METHODOLOGY 39
2.5 MARKET RANKING ESTIMATION 40
2.6 ASSUMPTIONS FOR THE STUDY 40

2.7 LIMITATIONS 41
2.7.1 METHODOLOGY-RELATED LIMITATIONS 41
2.7.2 SCOPE-RELATED LIMITATIONS 41
2.8 RISK ASSESSMENT 41
TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION) 42
FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 44
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE INFECTION SURVEILLANCE SOLUTIONS MARKET 45
4 PREMIUM INSIGHTS 46
4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW 46
FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH 46
4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE AND COUNTRY 47
FIGURE 18 ON-PREMISE SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020 47
4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 48
4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2019–2026) 49
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING THE FORECAST PERIOD 49
4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS 50
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET 51
5.2.1 MARKET DRIVERS 52
5.2.1.1 Growing global prevalence of COVID-19 52
TABLE 4 TOTAL NUMBER OF CONFIRMED COVID-19 CASES, BY REGION (AS OF AUGUST 23, 2021) 52
5.2.1.2 Increasing prevalence of hospital-acquired infections 53
5.2.1.3 Increasing adoption of antimicrobial stewardship programs 54
5.2.1.4 Increasing number of surgeries 54
TABLE 5 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 54
5.2.1.5 Growing geriatric population and the increasing incidence of chronic diseases 55
5.2.1.6 Growing investments to improve healthcare systems 56
5.2.2 MARKET RESTRAINTS 56
5.2.2.1 High cost of deployment for small healthcare organizations 56
TABLE 6 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2020 57
5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions 57
5.2.3 MARKET OPPORTUNITIES 58
5.2.3.1 Increasing consolidation in the healthcare industry 58
FIGURE 22 US: HOSPITAL MERGERS & ACQUISITIONS, 2015–2019 58
5.2.3.2 Cloud-based software solutions 59
5.2.3.3 Emerging markets 59
5.2.4 MARKET CHALLENGES 60
5.2.4.1 Shortage of skilled healthcare IT professionals 60
5.2.4.2 Data security concerns 60
6 INDUSTRY INSIGHTS 61
6.1 INTRODUCTION 61
6.2 INDUSTRY TRENDS 61
6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS 61
6.2.2 AI-POWERED SURVEILLANCE SOFTWARE 61
6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES 62
6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS 62
6.3 REGULATORY ANALYSIS 62
6.3.1 NORTH AMERICA 62
6.3.2 EUROPE 63
6.3.3 ASIA 63
6.3.4 MIDDLE EAST AND AFRICA 64
6.3.5 LATIN AMERICA 64
TABLE 7 KEY REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS 65
6.4 TECHNOLOGY ANALYSIS 67
6.4.1 CLOUD COMPUTING TECHNOLOGY 67
6.4.2 ARTIFICIAL INTELLIGENCE 67
TABLE 8 AI IN HEALTHCARE MARKET, BY REGION, 2017–2026 (USD MILLION) 67
6.4.3 BLUETOOTH LOW ENERGY SENSORS 67

6.5 ECOSYSTEM ANALYSIS 68
6.5.1 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS 68
6.5.2 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 68
6.6 PATENT ANALYSIS 69
6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS 69
FIGURE 23 PATENT PUBLICATION TRENDS (JANUARY 2011–AUGUST 2021) 69
6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 70
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2011–AUGUST 2021) 70
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2011–AUGUST 2021) 71
TABLE 9 LIST OF PATENTS/PATENT APPLICATIONS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET, 2020–2021 71
6.7 IMPACT OF COVID-19 ON THE INFECTION SURVEILLANCE SOLUTIONS MARKET 72
7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE 74
7.1 INTRODUCTION 75
TABLE 10 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 75
7.2 SOFTWARE 75
FIGURE 26 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2021–2026 (USD MILLION) 76
TABLE 11 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 76
TABLE 12 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 77
7.2.1 ON-PREMISE SOFTWARE 77
7.2.1.1 Data protection and in-house access to healthcare IT solutions to drive the growth of this market segment 77
TABLE 13 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 78
TABLE 14 ON-PREMISE INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 78
7.2.2 WEB-BASED SOFTWARE 79
7.2.2.1 Increasing demand for data centralization and cost-benefits of these solutions to drive their adoption 79
TABLE 15 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS 80
TABLE 16 WEB-BASED INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 80
7.3 INFECTION SURVEILLANCE SERVICES 81
FIGURE 27 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 81
TABLE 17 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 82
TABLE 18 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82

7.3.1 PRODUCT SUPPORT AND MAINTENANCE SERVICES 83
7.3.1.1 Growing trend of outsourcing for healthcare IT support to drive the growth of this market segment 83
TABLE 19 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.3.2 IMPLEMENTATION SERVICES 84
7.3.2.1 The need for regulatory compliance to abide by relevant healthcare IT laws and regulations to boost the growth of this market segment 84
TABLE 20 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 85
7.3.3 TRAINING & CONSULTING SERVICES 85
7.3.3.1 These services help end users enhance their understanding of systems and software solutions 85
TABLE 21 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 86
8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER 87
8.1 INTRODUCTION 88
TABLE 22 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 88
8.2 HOSPITALS 88
TABLE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 89
TABLE 24 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY COUNTRY, 2019–2026 (USD MILLION) 89
8.2.1 LARGE HOSPITALS 90
8.2.1.1 Growing need to deploy cloud-based solutions to drive the growth of this market segment 90
TABLE 25 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS,
BY COUNTRY, 2019–2026 (USD MILLION) 90
8.2.2 MEDIUM-SIZED HOSPITALS 91
8.2.2.1 Increasing demand for more specialized and advanced care to boost the growth of this market segment 91
TABLE 26 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 91
8.2.3 SMALL HOSPITALS 92
8.2.3.1 Growing need to decrease operational costs and increasing market competition to drive the growth of this market segment 92
TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS,
BY COUNTRY, 2019–2026 (USD MILLION) 92
8.3 LONG-TERM CARE FACILITIES 93
TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION) 94
8.3.1 NURSING HOMES 94
8.3.1.1 Growing geriatric population to drive the growth of this market segment 94
TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES,
BY COUNTRY, 2019–2026 (USD MILLION) 95
8.3.2 SKILLED NURSING FACILITIES 95
8.3.2.1 Advancements in healthcare IT solutions to drive the growth of this market segment 95
TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.3.3 ASSISTED LIVING FACILITIES 96
8.3.3.1 Growing geriatric population and the increasing need for quality care to drive the growth of this market segment 96
TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION) 97
8.4 OTHER END USERS 97
FIGURE 28 US: SURGICAL PROCEDURAL VOLUME, BY SETTING: AMBULATORY SURGERY CENTERS VS. HOSPITALS (2005–2020) 98
TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 99
9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION 100
9.1 INTRODUCTION 101
FIGURE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2021-2026) 101
TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION,
2019–2026 (USD MILLION) 102
9.2 IMPACT OF COVID-19 ON THE INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY COUNTRY/REGION 102
9.3 NORTH AMERICA 103
FIGURE 30 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 104
TABLE 35 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 36 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 105
TABLE 37 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 38 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 39 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 106
TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 106
9.3.1 US 107
9.3.1.1 Advanced medical infrastructure and increasing healthcare expenditure to drive the market growth 107
TABLE 42 US: KEY MACROINDICATORS 108
TABLE 43 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 108
TABLE 44 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 45 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 46 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 109
TABLE 47 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 110
9.3.2 CANADA 110
9.3.2.1 Growing adoption of technologically advanced HCIT solutions to propel market growth in Canada 110
TABLE 49 CANADA: KEY MACROINDICATORS 111
TABLE 50 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 111
TABLE 51 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 52 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 53 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 112
TABLE 54 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 113
9.4 EUROPE 113
TABLE 56 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 57 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 114
TABLE 58 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 59 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 60 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 115
TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 116
9.4.1 GERMANY 116
9.4.1.1 Increasing healthcare expenditure and growing adoption of healthcare IT solutions to drive market growth in Germany 116
TABLE 63 GERMANY: KEY MACROINDICATORS 117
TABLE 64 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 117
TABLE 65 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 66 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 67 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 118
TABLE 68 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 119
9.4.2 FRANCE 119
9.4.2.1 High healthcare spending and favorable government initiatives to drive market growth in France 119
TABLE 70 FRANCE: KEY MACROINDICATORS 120
TABLE 71 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 121
TABLE 72 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 73 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 74 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 122
TABLE 75 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 122
9.4.3 UK 123
9.4.3.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK 123
TABLE 77 UK: KEY MACROINDICATORS 123
TABLE 78 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 124
TABLE 79 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 80 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 81 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 125
TABLE 82 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 125
TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR
LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 125
9.4.4 ITALY 126
9.4.4.1 Increasing adoption of eHealth technologies to propel market growth in Italy 126
TABLE 84 ITALY: KEY MACROINDICATORS 126
TABLE 85 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 127
TABLE 86 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 87 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 88 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 128
TABLE 89 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 128
9.4.5 SPAIN 129
9.4.5.1 Increasing focus on improving the healthcare infrastructure and growing number of COVID-19 cases to support the market growth 129
TABLE 91 SPAIN: KEY MACROINDICATORS 129
TABLE 92 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 130
TABLE 93 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 94 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 95 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 131
TABLE 96 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 131
9.4.6 SWITZERLAND 132
9.4.6.1 Increasing demand for healthcare services and growing healthcare awareness to drive market growth 132
TABLE 98 SWITZERLAND: KEY MACROINDICATORS 132
TABLE 99 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 133
TABLE 100 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 101 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 102 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 134
TABLE 103 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 134
9.4.7 NETHERLANDS 135
9.4.7.1 Increasing healthcare initiatives to drive market growth in the Netherlands 135
TABLE 105 NETHERLANDS: KEY MACROINDICATORS 135
TABLE 106 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 136
TABLE 107 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 108 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 109 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 137
TABLE 110 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 137
9.4.8 REST OF EUROPE 138
TABLE 112 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 138
TABLE 113 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 114 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 115 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 139
TABLE 116 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 140
9.5 ASIA PACIFIC 140
FIGURE 31 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 141
TABLE 118 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 119 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 142
TABLE 120 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 121 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 122 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 143
TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET
FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 144
9.5.1 JAPAN 144
9.5.1.1 Increasing geriatric population to drive market growth in Japan 144
TABLE 125 JAPAN: KEY MACROINDICATORS 145
TABLE 126 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 145
TABLE 127 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 128 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 129 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 146
TABLE 130 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 147
9.5.2 CHINA 147
9.5.2.1 Healthcare infrastructure improvements in China to drive the market growth 147
TABLE 132 CHINA: KEY MACROINDICATORS 148
TABLE 133 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 148
TABLE 134 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 135 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 136 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 149
TABLE 137 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 150
9.5.3 INDIA 150
9.5.3.1 Increasing demand for healthcare IT solutions to drive market growth in India 150
TABLE 139 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 151
TABLE 140 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 141 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 142 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 152
TABLE 143 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS,
BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 152
9.5.4 AUSTRALIA AND NEW ZEALAND 153
9.5.4.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ 153
TABLE 145 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 154
TABLE 146 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 147 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 148 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 155
TABLE 149 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE,
2019–2026 (USD MILLION) 155
9.5.5 SOUTH KOREA 156
9.5.5.1 Increasing medical tourism to drive market growth in South Korea 156
TABLE 151 SOUTH KOREA: KEY MACROINDICATORS 156
TABLE 152 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 157
TABLE 153 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 154 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 155 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 158
TABLE 156 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 158
9.5.6 REST OF ASIA PACIFIC 159
TABLE 158 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 159
TABLE 159 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 160 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 161 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 160
TABLE 162 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 161
9.6 LATIN AMERICA 161
9.6.1 HEALTHCARE IT INITIATIVES TO DRIVE MARKET GROWTH IN THE REGION 161
TABLE 164 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 162
TABLE 165 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 166 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 167 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 163
TABLE 168 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET
FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 164

9.7 MIDDLE EAST & AFRICA 164
9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH 164
TABLE 170 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 165
TABLE 171 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET,
BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 172 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 173 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 166
TABLE 174 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION) 167
10 COMPETITIVE LANDSCAPE 168
10.1 OVERVIEW 168
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 168
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET 168
10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS 170
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 171
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET 171
10.5 MARKET RANKING ANALYSIS 172
TABLE 176 INFECTION SURVEILLANCE SOLUTIONS MARKET RANKING ANALYSIS, 2020 172
10.6 COMPETITIVE BENCHMARKING 173
TABLE 177 FOOTPRINT OF COMPANIES IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET 173
TABLE 178 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (20 COMPANIES) 174
TABLE 179 END-USER FOOTPRINT OF COMPANIES (20 COMPANIES) 175
TABLE 180 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES) 176
10.7 COMPETITIVE LEADERSHIP MAPPING 177
10.7.1 STARS 177
10.7.2 EMERGING LEADERS 177
10.7.3 PERVASIVE PLAYERS 177
10.7.4 PARTICIPANTS 178
FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 178
10.8 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES 179
10.8.1 PROGRESSIVE COMPANIES 179
10.8.2 DYNAMIC COMPANIES 179
10.8.3 STARTING BLOCKS 179
10.8.4 RESPONSIVE COMPANIES 179
FIGURE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2020) 180
10.9 COMPETITIVE SCENARIO 180
10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 181
TABLE 181 PRODUCT/SERVICE LAUNCHES/APPROVALS/ENHANCEMENTS, 2018–2021 181
10.9.2 DEALS 182
TABLE 182 DEALS, 2018–2021 182
10.9.3 OTHER DEVELOPMENTS 183
TABLE 183 OTHER DEVELOPMENTS, 2018–2021 183
11 COMPANY PROFILES 184
11.1 KEY PLAYERS 184
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
11.1.1 BECTON, DICKINSON AND COMPANY 184
TABLE 184 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 184
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 185
11.1.2 CERNER CORPORATION 188
TABLE 185 CERNER CORPORATION: BUSINESS OVERVIEW 188
FIGURE 36 CERNER CORPORATION: COMPANY SNAPSHOT (2020) 189
11.1.3 PREMIER, INC. 191
TABLE 186 PREMIER, INC.: BUSINESS OVERVIEW 191
FIGURE 37 PREMIER, INC.: COMPANY SNAPSHOT (2021) 192
11.1.4 IBM CORPORATION 195
TABLE 187 IBM CORPORATION: BUSINESS OVERVIEW 195
FIGURE 38 IBM CORPORATION: COMPANY SNAPSHOT (2020) 196
11.1.5 BAXTER INTERNATIONAL INC. 199
TABLE 188 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 199
FIGURE 39 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020) 200
11.1.6 GOJO INDUSTRIES, INC. 202
TABLE 189 GOJO INDUSTRIES, INC.: BUSINESS OVERVIEW 202
11.1.7 RLDATIX 204
TABLE 190 RLDATIX: BUSINESS OVERVIEW 204
11.1.8 WOLTERS KLUWER N.V. 207
TABLE 191 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW 207
FIGURE 40 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2020) 208
11.1.9 VIGILANZ CORPORATION 210
TABLE 192 VIGILANZ CORPORATION: BUSINESS OVERVIEW 210
11.1.10 DEB GROUP LTD. (SUBSIDIARY OF S.C. JOHNSON & SON, INC.) 212
TABLE 193 DEB GROUP LTD.: BUSINESS OVERVIEW 212
11.1.11 SUNQUEST INFORMATION SYSTEMS (SUBSIDIARY OF ROPER TECH.) 213
TABLE 194 SUNQUEST INFORMATION SYSTEMS: BUSINESS OVERVIEW 213
11.1.12 BIOVIGIL HEALTHCARE SYSTEMS INC. 215
TABLE 195 BIOVIGIL HEALTHCARE SYSTEMS INC.: BUSINESS OVERVIEW 215
11.1.13 ECOLAB INC. 216
TABLE 196 ECOLAB INC.: BUSINESS OVERVIEW 216
FIGURE 41 ECOLAB INC.: COMPANY SNAPSHOT (2020) 217
11.1.14 VECNA TECHNOLOGIES 219
TABLE 197 VECNA TECHNOLOGIES: BUSINESS OVERVIEW 219
11.1.15 BIOMÉRIEUX SA (SUBSIDIARY OF INSTITUT MERIEUX & SOFINA ) 220
TABLE 198 BIOMÉRIEUX SA: BUSINESS OVERVIEW 220
FIGURE 42 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020) 221
11.1.16 HARRIS HEALTHCARE GROUP (SUBSIDIARY OF N. HARRIS COMPUTER CORPORATION) 223
TABLE 199 HARRIS HEALTHCARE GROUP: BUSINESS OVERVIEW 223
11.1.17 PERAHEALTH INC. 225
TABLE 200 PERAHEALTH INC.: BUSINESS OVERVIEW 225
11.1.18 MEDEXTER HEALTHCARE GMBH 227
TABLE 201 MEDEXTER HEALTHCARE GMBH: BUSINESS OVERVIEW 227
11.1.19 CENTRAK, INC. (SUBSIDIARY OF HALMA PLC) 228
TABLE 202 CENTRAK, INC.: BUSINESS OVERVIEW 228
11.1.20 CKM HEALTHCARE INCORPORATED 230
TABLE 203 CKM HEALTHCARE INCORPORATED: BUSINESS OVERVIEW 230
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 231
11.2.1 ASOLVA INC.: COMPANY OVERVIEW 231
11.2.2 POINTCLICKCARE: COMPANY OVERVIEW 231
11.2.3 STANLEY HEALTHCARE: COMPANY OVERVIEW 232
11.2.4 VITALACY, INC.: COMPANY OVERVIEW 232
11.2.5 VIZZIA TECHNOLOGIES: COMPANY OVERVIEW 233
12 APPENDIX 234
12.1 INSIGHTS FROM INDUSTRY EXPERTS 234
12.2 DISCUSSION GUIDE 235
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 239
12.4 AVAILABLE CUSTOMIZATIONS 241
12.5 RELATED REPORTS 241
12.6 AUTHOR DETAILS 242